These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 17088652

  • 1. Prospects for peptide-based immunotherapy for dog allergy.
    Virtanen T.
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):461-5. PubMed ID: 17088652
    [Abstract] [Full Text] [Related]

  • 2. Use of multiple peptides containing T cell epitopes is a feasible approach for peptide-based immunotherapy in Can f 1 allergy.
    Immonen AK, Taivainen AH, Närvänen AT, Kinnunen TT, Saarelainen SA, Rytkönen-Nissinen MA, Virtanen TI.
    Immunology; 2007 Jan; 120(1):38-46. PubMed ID: 17233739
    [Abstract] [Full Text] [Related]

  • 3. The major horse allergen Equ c 1 contains one immunodominant region of T cell epitopes.
    Immonen A, Kinnunen T, Sirven P, Taivainen A, Houitte D, Peräsaari J, Närvänen A, Saarelainen S, Rytkönen-Nissinen M, Maillere B, Virtanen T.
    Clin Exp Allergy; 2007 Jun; 37(6):939-47. PubMed ID: 17517108
    [Abstract] [Full Text] [Related]

  • 4. Immunomodulatory potential of heteroclitic analogs of the dominant T-cell epitope of lipocalin allergen Bos d 2 on specific T cells.
    Kinnunen T, Kwok WW, Närvänen A, Rytkönen-Nissinen M, Immonen A, Saarelainen S, Taivainen A, Virtanen T.
    Int Immunol; 2005 Dec; 17(12):1573-81. PubMed ID: 16221722
    [Abstract] [Full Text] [Related]

  • 5. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
    Hiroi T, Takaiwa F.
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651
    [Abstract] [Full Text] [Related]

  • 6. T cell epitope-containing peptides of the major dog allergen Can f 1 as candidates for allergen immunotherapy.
    Immonen A, Farci S, Taivainen A, Partanen J, Pouvelle-Moratille S, Närvänen A, Kinnunen T, Saarelainen S, Rytkönen-Nissinen M, Maillere B, Virtanen T.
    J Immunol; 2005 Sep 15; 175(6):3614-20. PubMed ID: 16148105
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunotherapy with peptides.
    Moldaver D, Larché M.
    Allergy; 2011 Jun 15; 66(6):784-91. PubMed ID: 21507007
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of peptides containing T-cell epitopes of Japanese cedar (Cryptomeria japonica) pollen allergen (Cry j 1) in dogs.
    Masuda K, Sakaguchi M, Saito S, Yasueda H, Iwabuchi S, Tsukui T, Hayashi N, Nakao Y, Kurata K, Maeda S, Ohno K, Tsujimoto H.
    Vet Immunol Immunopathol; 2004 Nov 15; 102(1-2):45-52. PubMed ID: 15451614
    [Abstract] [Full Text] [Related]

  • 11. Allergen-related approaches to immunotherapy.
    Rolland JM, Gardner LM, O'Hehir RE.
    Pharmacol Ther; 2009 Mar 15; 121(3):273-84. PubMed ID: 19111571
    [Abstract] [Full Text] [Related]

  • 12. Epitope peptides and immunotherapy.
    Tanabe S.
    Curr Protein Pept Sci; 2007 Feb 15; 8(1):109-18. PubMed ID: 17305564
    [Abstract] [Full Text] [Related]

  • 13. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
    Valenta R, Vrtala S, Focke-Tejkl M, Bugajska-Schretter, Ball T, Twardosz A, Spitzauer S, Grönlund H, Kraft D.
    Biol Chem; 1999 Feb 15; 380(7-8):815-24. PubMed ID: 10494830
    [Abstract] [Full Text] [Related]

  • 14. Peptide immunotherapy for allergic diseases.
    Larché M.
    Allergy; 2007 Mar 15; 62(3):325-31. PubMed ID: 17298351
    [Abstract] [Full Text] [Related]

  • 15. Peptide therapy for allergic diseases: basic mechanisms and new clinical approaches.
    Larché M.
    Pharmacol Ther; 2005 Dec 15; 108(3):353-61. PubMed ID: 16014312
    [Abstract] [Full Text] [Related]

  • 16. Latex allergy: a model for therapy.
    Rolland JM, O'Hehir RE.
    Clin Exp Allergy; 2008 Jun 15; 38(6):898-912. PubMed ID: 18498539
    [Abstract] [Full Text] [Related]

  • 17. Intraoral administration of a T-cell epitope peptide induces immunological tolerance in Cry j 2-sensitized mice.
    Yoshitomi T, Nakagami Y, Hirahara K, Taniguchi Y, Sakaguchi M, Yamashita M.
    J Pept Sci; 2007 Aug 15; 13(8):499-503. PubMed ID: 17600865
    [Abstract] [Full Text] [Related]

  • 18. Analysis of helper T cell responses to Cry j 1-derived peptides in patients with nasal allergy: candidate for peptide-based immunotherapy of Japanese cedar pollinosis.
    Masuyama K, Chikamatsu K, Ikagawa S, Matsuoka T, Takahashi G, Yamamoto T, Endo S.
    Allergol Int; 2009 Mar 15; 58(1):63-70. PubMed ID: 19050376
    [Abstract] [Full Text] [Related]

  • 19. T-cell epitopes of aeroallergens.
    Letz AG, Calabria CW.
    Ann Allergy Asthma Immunol; 2009 Jun 15; 102(6):445-51; quiz 452-4, 499. PubMed ID: 19558001
    [Abstract] [Full Text] [Related]

  • 20. Peptide based immunotherapy: a pivotal tool for allergy treatment.
    Gupta K, Kumar S, Das M, Dwivedi PD.
    Int Immunopharmacol; 2014 Apr 15; 19(2):391-8. PubMed ID: 24530919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.